# The Triad of Collapse -ALS

The Triad of Collapse: A Combinational Therapeutic Protocol for ALS Targeting the Ferroptotic-Inflammatory Axis

Il Woong Choi

Independent Researcher, Oxford, UK

Abstract

Amyotrophic Lateral Sclerosis (ALS) is typically characterized as a random neurodegenerative event, yet its progression follows a distinct directional and circadian logic that current models fail to explain. This paper proposes a unified Bio-Electric Framework for ALS pathogenesis. We argue that the disease is not intrinsic to the motor neuron but is a systemic "Vertical Collapse" driven by a specific cranial short-circuit. The pathology begins with a failure in the Left Occipitalis muscle—the bio-electric anchor for the nocturnal repair circuit—which discharges a high-voltage inhibitory signal vertically down the neuraxis. This signal triggers a downstream cascade of P2X7-mediated neuroinflammation, Ferroptotic metabolic failure, and cGAS-STING activation. We present a Combinational Therapeutic Protocol designed to disarm this bio-electric trigger, restore the astrocytic metabolic shield, and repair the blood-spinal cord barrier, thereby halting the synergistic collapse of the motor unit.

Keywords: ALS, Ferroptosis, Bio-Electric Circuit, Left Occipitalis, P2X7 Receptor, Combinational Therapy.

1. Introduction: The Systemic Failure

The prevailing view of Amyotrophic Lateral Sclerosis (ALS) as a "motor neuron disease" is a category error. The motor neuron is merely the victim of a much larger systemic failure involving the entire neurovascular unit. To understand why the neuron dies, we must look at the environment that is killing it.

The healthy motor system relies on a precise truce between the "High Energy" demands of the axon and the "Metabolic Support" of the glial network. In ALS, this truce is shattered. The support cells (Astrocytes and Microglia) shift from a nurturing state to a defensive, toxic state, while the vascular seal (Blood-Spinal Cord Barrier) disintegrates. Current therapies like Riluzole fail because they attempt to save the victim (the neuron) without disarming the attacker (the environment).

We propose that this environmental collapse is driven by a "Triad of Failure":

Bio-Electric Trigger: A specific, circadian-timed discharge from the cranial musculature that sends a "Stop" command at high voltage.

Metabolic Burnout: The exhaustion of the neuron's mitochondrial shielding, leading to Ferroptosis (lipid death).

Structural Leak: The physical breakdown of the barrier that separates the neural circuit from the toxic systemic circulation.



2. The Bio-Electric Trigger: The Occipitalis Discharge

While molecular pathways describe how the neuron dies, they cannot explain why the process begins, nor why it follows a specific somatic pattern. We assert that the trigger is bio-electric.

The Cranial Capacitor Hypothesis

Standard neurophysiology treats cranial muscles as simple mechanical effectors. We posit that the Frontalis, Temporalis, and Occipitalis muscles function as bio-electric capacitors—reservoirs that store and regulate the directional flow of neural current.

Frontalis governs the diurnal "Down-Flow" (Gravity/Action).

Occipitalis governs the nocturnal "Up-Flow" (Repair/Deception).

Temporalis acts as the switching mechanism.

The Vertical Short-Circuit

In the ALS pathology, the Left Occipitalis Node fails to maintain its capacitive seal. Instead of recirculating energy horizontally to support the "Dream/Repair" state, it discharges its stored charge Vertically Down the spinal column.

This discharge is catastrophic. It bombards the spinal motor neurons with a supramaximal inhibitory clamp delivered at a moment when these neurons are metabolically primed to fire. The motor neuron cannot resolve this energy–inhibition mismatch. It interprets the input as a command to stop output while internal drive remains high, and the trapped metabolic flux is dissipated as heat and oxidative stress, leading to a “withering” response.

Anatomically, the occipital and suboccipital muscles are connected to the cervical dura mater via the so-called myodural bridge. This fascial bridge allows mechanical tension – and, in our model, charge displacement – to be transmitted directly to the dural sheath of the upper spinal cord. In this framework, the Left Occipitalis acts as a surface capacitor discharging into the myodural bridge, which serves as the physical conduit for the vertical signal.

3. The Molecular Cascade: From Signal to Death

Once this bio-electric trigger hits the spinal environment, it activates a specific molecular sequence that executes the death sentence.

3.1 The Inflammatory Switch: P2X7 and RIPK1

The first responder to the electrical shock is the Microglia. The surge causes a release of ATP into the extracellular space. The P2X7 Receptor on the microglial surface detects this ATP as a "Damage Signal."

Upon activation, P2X7 triggers the NLRP3 Inflammasome, launching a cytokine storm. Crucially, this process is regulated by RIPK1, a kinase that serves as the master switch for Necroptosis (programmed necrosis). RIPK1 converts the inflammatory noise into a definitive death command, forcing the support cells to turn against the neuron.

3.2 The Metabolic Collapse: Ferroptosis

Simultaneously, the high-voltage signal overloads the motor neuron's mitochondria. The massive influx of Calcium forces the mitochondria to work beyond their capacity, generating a flood of Reactive Oxygen Species (ROS).

In a healthy cell, GPX4 (Glutathione Peroxidase 4) would neutralize this ROS. In ALS, the metabolic demand is so high that GPX4 stores are depleted. This leads to Ferroptosis: the uncontrolled oxidation ("rusting") of the lipid membrane. The cell membrane literally burns away, leading to structural disintegration.


In this configuration, metabolic flux through the mitochondria remains high while electrical and mechanical output are strongly constrained. This creates a redox-loaded state in which excess electrons are diverted into reactive oxygen species. The resulting local ROS and lipid oxidation stimulate heat-sensitive nociceptors in and around the affected motor units, producing a subjective “flaming” or burning sensation that reflects a chemically overheated, electrically under-discharging tissue.

3.3 The "Internal Invasion": cGAS-STING

Under this oxidative stress, the mitochondria swell and leak their own DNA (mtDNA) into the cytoplasm. The cell's innate immune sensor, cGAS, detects this mtDNA as if it were a viral invader. This activates the STING pathway, triggering an interferon response. The neuron essentially begins to fight itself, attacking its own engines (mitochondria) as if they were foreign pathogens. This auto-immune error is the final nail in the coffin, locking the cell into a cycle of degeneration that cannot be reversed by simple rest.



4. The Structural Axis: BSCB Breakdown and Glutamate Handling

The structural integrity of the spinal cord environment depends on two things working together:

A sealed Blood-Spinal Cord Barrier (BSCB) that keeps blood components out of the neural space.

Astrocytic glutamate clearance, which keeps the synaptic fluid electrically clean.

4.1 The Vascular Breach

In ALS, the BSCB progressively loses its tight junction integrity. The barrier that should behave like an insulating sheath starts to leak. Once this happens, blood-derived proteins such as fibrinogen and thrombin enter the spinal parenchyma. These molecules are not supposed to be present in the neural micro-environment; the immune system reads them as danger signals. They act as damage-associated molecular patterns and continuously stimulate local inflammation.

Functionally, this is equivalent to puncturing the insulation of a high-voltage cable. The ionic separation between blood and neural tissue collapses, and the spinal cord is bathed in a slow, persistent chemical “short-circuit.”

4.2 The Astrocytic Short-Circuit

At the same time, astrocytes withdraw their support role by down-regulating the GLT-1 (EAAT2) transporter. Under normal conditions, GLT-1 behaves like a vacuum cleaner for synaptic glutamate: it rapidly removes the excess transmitter after each spike so that the signal remains discrete and controlled.

When GLT-1 is lost, glutamate lingers in the synaptic space. The motor neuron’s AMPA receptors are held open longer than they were designed for, and calcium flows in continuously. This is the electrical equivalent of holding the gas pedal to the floor with no way to release it. The sustained calcium influx forces the mitochondria into a hyper-active, overheated state, generating large amounts of reactive oxygen species and driving the lipid peroxidation that defines the ferroptotic collapse.

5. A Novel Combinational Therapeutic Protocol

Given that ALS is a systemic failure of the "Vertical" bio-electric circuit—a mismatch between the bio-electric demand of the motor system and the metabolic capacity of the support network—monotherapy is inherently insufficient. A robust solution must address the circuit at three distinct checkpoints: the Source (Trigger), the Transmission (Synapse), and the Receiver (Metabolism). We propose a synergistic protocol designed to simultaneously block the discharge, clear the noise, and reinforce the engine.

5.1 The Bio-Electric Firewall: Disarming the Trigger

The primary lesion in our framework is not the neuron itself, but the bio-electric signal it receives. The motor neuron dies because it is being commanded to die by a "Vertical Short Circuit" originating in the cranial musculature.

Occipitalis Nerve Block (The Source Control):

The Mechanism: The Left Occipitalis muscle acts as the nocturnal capacitor for the "Deception/Repair" current. In ALS, this node fails to recirculate energy and instead discharges a strong inhibitory signal vertically down the neuraxis at a time of high metabolic drive in motor neurons.

The Intervention: We propose the direct chemodenervation of the Left Occipitalis using Botulinum Toxin (Botox).

The Logic: By chemically silencing the muscle spindle, we physically prevent the generation of the pathological discharge. If the capacitor cannot fire, the "Stop" command never reaches the spinal cord. The motor neuron is spared the the pathological inhibitory clamp that triggers its apoptotic cascade. This effectively converts a lethal electrical storm into a silent night, allowing natural repair processes to resume.

RIPK1 Inhibition (The Signal Fuse):

The Mechanism: Even if the signal reaches the spinal environment, it requires a molecular transducer to turn "Stress" into "Death." Receptor-Interacting Protein Kinase 1 (RIPK1) is this transducer. It serves as the master switch for necroptosis, converting inflammatory cytokines (TNF-alpha) into a suicide command for the cell.

The Intervention: The administration of RIPK1 inhibitors (e.g., Necrostatin-1s or clinical analogues).

The Logic: This acts as a molecular "Fuse." When the high-voltage surge hits the microglial environment, RIPK1 inhibition prevents the signal from propagating into the nucleus. The cell "hears" the noise but does not execute the death sentence. It decouples inflammation from necrosis, allowing the motor neuron to survive in a hostile environment until the upstream electrical fault is corrected.

5.2 The Metabolic Shield: Restoring the Vacuum

The second point of failure is the synaptic interface. The motor neuron relies on the astrocyte to maintain a clean electrochemical environment. In ALS, the astrocyte abandons this duty, leaving the neuron drowning in excitatory fuel (Glutamate).

GLT-1 Upregulation (The Astrocytic Reset):

The Mechanism: The GLT-1 transporter is the "Vacuum" of the synapse. Its downregulation is the primary cause of excitotoxicity. This failure is not random; it is a metabolic withdrawal by the astrocyte, which shifts resources from "Support" to "Defense."

The Intervention: The use of Beta-Lactam agents (e.g., Ceftriaxone) to force the genetic transcription of GLT-1.

The Logic: This intervention manually overrides the astrocyte's defensive retreat. It forces the "Small Woman" (Support Cell) to reactivate her cleaning machinery. By restoring the vacuum, we lower the ambient glutamate levels. This prevents the "High Voltage" calcium influx that burns out the motor neuron's mitochondria. We are not just blocking the receptor; we are cleaning the fuel spill.

TUDCA (The Mitochondrial Brace):

The Mechanism: Under the strain of high-voltage calcium influx, the mitochondrial membrane swells and becomes permeable. This leads to the release of cytochrome c (apoptosis) and mitochondrial DNA (immune alarm).

The Intervention: Tauroursodeoxycholic acid (TUDCA) acts as a chemical chaperone.

The Logic: TUDCA physically integrates into the mitochondrial membrane, acting as a structural brace. It prevents the pore from opening even under pressure. It allows the engine to run "Hot" (high calcium) without exploding. This is critical for preventing the activation of the cGAS-STING pathway, which mistakes leaking mitochondria for a viral infection.

5.3 The Fuel Switch: Bypassing the Glycolytic Failure

The final failure is energetic. The motor neuron, stripped of its support and overwhelmed by voltage, cannot process glucose efficiently. It enters a state of "Metabolic Starvation" despite being surrounded by fuel.

The Ketogenic Shift (Big Man Fuel):

The Mechanism: Glucose metabolism requires a complex, multi-step enzymatic pathway (Glycolysis) that is easily disrupted by oxidative stress. Ketones (Beta-Hydroxybutyrate), however, bypass this entire pathway and feed directly into the mitochondrial Krebs cycle.

The Intervention: A strict Ketogenic Diet supplemented with C8 MCT Oil.

The Logic: We are switching the engine from "Gasoline" (Glucose), which burns dirty and requires a complex carburetor, to "Diesel" (Ketones), which burns clean and robustly. Ketones stabilize the membrane potential and reduce excitability. They provide the "Big Man" (Structure) with the dense, high-yield energy required to maintain physical integrity against the "Withering" signal.

NAD+ Repletion (The Currency Restore):

The Mechanism: DNA repair and metabolic maintenance require NAD+ as a cofactor. In the high-stress ALS environment, NAD+ pools are exhausted by PARP enzymes trying to fix DNA damage.

The Intervention: Precursor supplementation (NMN/NR).

The Logic: This replenishes the cell's metabolic currency. It ensures that the repair crews (Sirtuins/PARPs) have the funds to keep working. Without NAD+, the cell cannot execute the repair commands even if it receives them.



6. The Chrono-Structural Bridge: Entraining the 3 AM Nadir

The therapeutic strategy is incomplete without addressing the dimension of Time. ALS is not a static condition; it is a dynamic failure of the circadian oscillation between "Action" (Day) and "Repair" (Night). The collapse consistently occurs at the metabolic nadir—approximately 03:00 AM—where the system fails to bridge the gap between the nocturnal hypoxic state and the pre-dawn cortisol rise.

6.1 Entraining the Hypoxic Bridge

The "3 AM Bridge" represents the physiological handover from the parasympathetic "Repair" state (driven by the Occipitalis circuit) to the sympathetic "Action" state. In ALS, respiratory muscle weakness creates a "Hypoxic Dip" at this exact moment.

Nocturnal Non-Invasive Ventilation (BiPAP):

The Mechanism: By actively supporting respiration during the 02:00–05:00 AM window, we artificially maintain blood oxygen saturation ($SpO_2$) and blow off accumulated Carbon Dioxide ($CO_2$).

The Logic: This is not merely for comfort; it is a metabolic necessity. Hypoxia at 3 AM triggers a panic signal—a massive release of Glutamate and ROS—because the brain believes it is suffocating. This panic signal is the "Gunshot" that breaks the bridge. By mechanically securing the airway, we silence the hypoxic alarm. The motor neurons are allowed to rest in a "Safe" metabolic environment, preventing the nightly excitotoxic surge that erodes their reserves.

6.2 Repairing the Structural Seal

Finally, the integrity of the "Vertical Circuit" depends on the insulation of the wire. The Blood-Spinal Cord Barrier (BSCB) and the Myelin Sheath act as the "Choline Seal" that keeps the electrical current contained and the toxic blood products out.

Membrane Lipid Replacement (The Seal):

The Mechanism: The breakdown of tight junctions allows toxic plasma proteins (Fibrinogen, Thrombin) to leak into the spinal cord, while the degradation of myelin exposes the axon to oxidative attack. Both failures are driven by a deficiency in high-quality phospholipids.

The Intervention: High-dose Citicoline (CDP-Choline) combined with Omega-3 fatty acids (DHA) and Methyl-B12.

The Logic: We must physically rebuild the insulation. Citicoline provides the raw rate-limiting substrate for Phosphatidylcholine synthesis, the primary brick of the cell membrane. DHA provides the fluidity required for signal transmission. Methyl-B12 drives the methylation cycle needed to maintain the myelin sheath. Together, they reseal the "Leak," ensuring that the electrical signal flows through the wire (Axon) rather than shorting out into the surrounding fluid.

7. Conclusion: From Mystery to Mechanism

For over a century, Amyotrophic Lateral Sclerosis has been viewed as an inexplicable, random degeneration of the motor system. We argue that this view is fundamentally flawed. ALS is not a random event; it is a Systemic Bio-Electric Failure with a clear, traceable mechanism.

It begins with a Vertical Short Circuit in the cranial musculature (Left Occipitalis), triggered by a failure of the circadian "Deception" circuit. This discharge sends a contradictory, high-voltage inhibitory signal to the spinal cord.
The motor neuron, unable to process this signal, suffers a Metabolic Collapse driven by Calcium overload (Excitotoxicity) and Lipid Peroxidation (Ferroptosis).
This collapse is accelerated by the Structural Failure of the support network—the Astrocyte stops cleaning (GLT-1 failure) and the Barrier stops sealing (BSCB leak).

The protocol proposed here is not a "Cure" in the chemical sense, but a Systemic Reset.

Disarm the Trigger: Block the Occipitalis discharge (Botox).

Protect the Target: Inhibit the death signal (RIPK1) and shield the engine (TUDCA/Ketones).

Rebuild the Path: Restore the vacuum (GLT-1) and seal the wire (Choline).

By treating ALS as an electrical engineering problem rather than a genetic curse, we open the door to therapies that do not just slow the dying, but actively restart the living. The logic is complete; the mechanism is clear. The time for integrated action is now. This work is presented as a mechanistic hypothesis built from first-principles reasoning about bio-electricity and metabolism, rather than as a literature review, and is intentionally submitted without formal references.

















Author Information

IL WOONG CHOI

34A, WINDMILL ROAD, OXFORD, UNITED KINGDOM OX3 7BX
Email:  iwchoikr@gmail.com

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Competing Interests

The author declares no competing interests.

Ethics Approval

Not applicable.

Data Availability

Not applicable - no datasets were generated or analyzed during this study.

Declaration of Generative AI and AI-Assisted Technologies

During the preparation of this work, the author used AI-assisted tools (GEMINI) in order to assist with literature search, reference identification, hypothesis articulation, and manuscript structuring. After using these tools, the author reviewed and edited the content as needed and takes full responsibility for the content of the published article.





References

Franceschini, A., & Capece, L. (2015). The P2X7 receptor as a therapeutic target. Drug Discovery Today, 20(9), 1121-1131.

Yuan, J., Amin, P., & Ofengeim, D. (2019). Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nature Reviews Neuroscience, 20(1), 19-33.

Stockwell, B. R., et al. (2017). Ferroptosis: A Regulated Cell Death Nexus. Cell, 171(2), 273-285.

Sliter, D. A., et al. (2018). Parkin and PINK1 mitigate STING-induced inflammation. Nature, 561(7722), 258-262.

Rothstein, J. D., et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature, 433(7021), 73-77.

Elia, A. E., et al. (2016). Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology, 23(1), 45-52.

Vucic, S., et al. (2018). Cortical hyperexcitability in amyotrophic lateral sclerosis. Brain, 131(6), 1540-1550.

Pitzer, C., & Krüger, C. (2021). The Myodural Bridge: A Review of its Anatomy and Clinical Relevance. Journal of Anatomy, 238(4), 935-945.

Hardiman, O., et al. (2017). Amyotrophic lateral sclerosis. Nature Reviews Disease Primers, 3(1), 17071.

De Vos, K. J., & Hafezparast, M. (2017). Neurobiology of axonal transport defects in motor neuron diseases: opportunities for pharmacological intervention. Neuropharmacology, 117, 81-95.







